New Delhi, March 29, 2019: Sharda University, Greater Noida, India & CosmoStem Institute of Regenerative Aesthetic Medicine (A Brand Of StemMax Research & Therapeutics Pvt Ltd) signed an MOU on 27th March, 2019 at their campus to start various Stem Cell & Regenerative Medicine Courses in the university. The university will now be providing M.Sc, Post Graduate Diploma and Certificate Courses in Stem Cell Technology & Regenerative Medicine.
Prof. G.R.C. Reddy, Vice Chancellor, Prof. Parma Nand, Dean (SET), Registrar Mr. Amal Kumar, Mr. D.L.N. Shastri, Director, Corporate Affairs & Strategy, Dr. Saurabh Kumar Jha and other senior officers of Sharda University were present during the signing of the MOU and they shared their insight and acknowledged it as a major milestone in Biotechnology and Healthcare industry and also said that Stem Cell & Regenerative Medicine is future of Healthcare and Medicine.
Mr. Prabhu Mishra & Dr. Deepti Dua, Founder of CosmoStem & Chief Scientific said on the occasion, “It is great amalgamation of Industry and academia collaboration for the betterment of the students. They will receive better opportunities to learn latest advances, practical knowledge and novel technologies. The students will also get the opportunities to translate ideas into their innovation & technologies. We are very much hopeful with this collaboration students will come with in-house technologies, new MedTech companies and take out university and country to global level in stem cell science”.
Sharda University collaborates with CosmoStem Institute of Regenerative Aesthetic Medicine
Regenerative medicine is an exciting and multifaceted new development in the world of medical treatment. It promises novel therapeutic approaches to replace or restore the original functions of tissues, functional systems or even entire organs. The objective behind initiating Stem Cell and Regenerative Medicine courses in the university is to encourage the study of regenerative medicine which has the potential to help scientists and clinicians devise early-intervention treatments for traumatic injury or degenerative diseases, by regrowth or replacement of cells or tissues.
“Stem-cell and gene therapies represent a major revolution in medicine. They also represent a revolution for patients, shifting the focus from treatment to healing. While, the bulk of the innovation will continue to come from chemical and biological compounds, we see a growing pipeline of stem-cell and gene therapies that will play an important role in the pharmaceutical market of the future” said Dr. Parmanand, Dean SET, Sharda University.